Anti-phospho-Insulin Receptor/Insulin-Like Growth Factor-1 Receptor (pTyr1158) Y062093|产品详情|进口橙子视频旧款采购网

您好，欢迎来到橙子视频app安卓下载生物网站！请登录注册

我的订单 | 联系橙子视频app安卓下载 | 在线客服QQ：3012681483 | 客服电话：400-968-7988 | 工作时间：08:30-17:30

主营产品： ELISA91橙子视频、抗体、补体血清、兔补体、干扰素、小鼠测温仪、进口橙子视频旧款、Quidel代理、Swant代理、PBL Assay Science代理

所在位置：首页 > 产品中心 > abmgood > abmgood产品

订购信息

上海橙子视频app安卓下载生物科技公司

Tel:400-968-7988 021-33779008

Anti-phospho-Insulin Receptor/Insulin-Like Growth Factor-1 Receptor (pTyr1158)

品牌：Abmgood

货号：Y062093

规格：

货期：

立即购买加入购物车

Anti-phospho-Insulin Receptor/Insulin-Like Growth Factor-1 Receptor (pTyr1158) produced in rabbit Antibody

商品详情参考文献相关资料

Overview	Print Version
Product Name	Anti-phospho-Insulin Receptor/Insulin-Like Growth Factor-1 Receptor (pTyr1158) produced in rabbit Antibody
Description	Anti-phospho-Insulin Receptor/Insulin-Like Growth Factor-1 Receptor (pTyr¹¹⁵⁸) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution
Subtype	polyclonal
Application	WB,ICC/IF
Raised In	rabbit
Immunogen	synthetic phosphopeptide derived from the region of human IR/IGF1R that contains tyrosine 1158.
Guarantee	abm guarantees that all our Anti-phospho-Insulin Receptor/Insulin-Like Growth Factor-1 Receptor (pTyr1158) produced in rabbit Antibody will perform as described on this product webpage, if this is not the case we will provide you with a one-time replacement at no extra cost. Documentation and explanation of experiment conducted will be required when submitting a claim for replacement.
Properties
Formulation	Liquid
Quantity	50 μg
Storage	This product is stable for several weeks at 4°C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20°C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt.
Storage Buffer	PBS, pH 7.4 with 0.05% sodium azide.
Concentration	1µg/ul
Purity	affinity isolated antibody
Species Reactivity	rat, mouse, human
Specific References
Y062093 has not yet been referenced specifically in any publications.